AIP
ATRC icon

Almanack Investment Partners’s AtriCure ATRC Stock Holding History

Almanack Investment Partners’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,098
Closed -$43K – 249
2022
Q3 		$43K Buy
+1,098
New +$50.2K 0.01% 283

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Almanack Investment Partners's ATRC Position: Q4 2022 in Review

Almanack Investment Partners sold out of AtriCure (ATRC) in Q4 2022, closing a stake of 1,098 shares — an estimated $43K sold.

Almanack Investment Partners first reported a position in ATRC in Q3 2022 and held it in 1 quarter. The position peaked at $43K in Q3 2022. 211 funds tracked by Wall St. Rank hold ATRC as of Q4 2022.

  • Almanack Investment Partners reported no remaining AtriCure position as of Q4 2022 after selling out during the quarter.
  • Almanack Investment Partners sold 1,098 AtriCure shares in Q4 2022, an estimated $43K.
  • Almanack Investment Partners first reported a position in AtriCure in Q3 2022 and held it in 1 quarter.
  • Almanack Investment Partners's AtriCure position peaked at $43K in Q3 2022.
  • 211 funds tracked by Wall St. Rank held AtriCure as of Q4 2022.

Based on Almanack Investment Partners's 13F filing for Q4 2022, filed 9 Feb 2023.